{
  "pmcid": "4718147",
  "sha256": "cdc474adb7204d40a7abaf124ae99cc53dd0494b2ea43a3190d530df732c9e9b",
  "timestamp_utc": "2025-11-09T23:54:43.939347+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.954486626402073,
    "reading_ease": 32.22813201035376,
    "word_count": 244
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Dexketoprofen/Tramadol for Postoperative Pain Management"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "Conducted as a multicentre, randomised, double-blind, double-dummy, placebo- and active-controlled trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "641 patients aged 18–80 years were enrolled across 37 sites in 10 countries"
      },
      "Intervention": {
        "score": 2,
        "evidence": "dexketoprofen/tramadol 25 mg/75 mg fixed-dose combination compared to dexketoprofen 25 mg and tramadol 100 mg"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to assess the analgesic efficacy and safety of a dexketoprofen/tramadol 25 mg/75 mg fixed-dose combination"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the mean sum of pain intensity differences (SPID) over 8 hours post-dose"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Participants were randomised using an Interactive Voice/Web Response system with allocation concealment"
      },
      "Blinding": {
        "score": 2,
        "evidence": "double-blind"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 641 patients were randomised: 213 to dexketoprofen/tramadol, 214 to dexketoprofen, and 214 to tramadol"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The combination was superior to dexketoprofen (P=0.019; 95% CI 6.4–73) and tramadol (P=0.012; 95% CI 9.5–76)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse drug reactions were low and similar across groups, with 2.8% in the combination group, 4.7% in the dexketoprofen group, and 5.1% in the tramadol group"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: EudraCT 2012-004548-31; ClinicalTrials.gov NCT01902134"
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Menarini Group"
      }
    },
    "total_score": 23,
    "max_score": 25
  }
}